Texas A&M Football

Damontre Moore shares thoughts on A&M's top players entering 2026

With just 10 days until kickoff, former Texas A&M defensive lineman Damontre Moore joined us on Tuesday's edition of TexAgs Live to share his thoughts on Mike Elko's leadership, Marcel Reed's growth ahead of the 2026 season and more.
By David Nuño
August 26, 2026
2.5k Views
Discuss
Story Poster
Photo by Andrew Kilzer, TexAgs
Free Preview
Watch the full version by becoming a Premium subscriber.
Try Premium for $1
No Thanks
Trial available for new subscribers only.

Key notes from Damontre Moore interview

  • It is a wild time in the wild west. Personally, I don't like NFL players trying to come back to college football. This fits with the saying, "If you give someone an inch, they will take a quarter mile.” Parents have been holding back their kids for a year or two. Reclassifications have been on the rise. If this becomes allowed, I don't blame these athletes. It is a great opportunity.
To watch the full version of this video feature, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko TexAgs Live NFL Draft TexAgs Live Feature Ryan Tannehill Ryan Swope Mike Evans Johnny Manziel Damontre Moore NIL Transfer Portal Marcel Reed
Show All
Mario Craver Football Texas A&M 2026
More Football
See All →
Game Highlights: Louisiana State 35, Texas A&M 6
By Andrew Wu
12 Key Statistics: Louisiana State 35, Texas A&M 6
By Luke Evangelist
Learned, Loved, Loathed: Louisiana State 35, Texas A&M 6
By Olin Buchanan
LSU Snap Counts
By Luke Evangelist
Discussion from...

Damontre Moore shares thoughts on A&M's top players entering 2026

1,436 Views | 0 Replies | Last: 1 mo ago by David Nuño
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.